Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells

Evaggelia Liaskou, Samita Patel, Gwilym Webb, Danai Bagkou Dimakou, Sarah Akiror, Mahesh Krishna, George F Mells, David Jones, Simon Bowman, Francesca Barone, Benjamin Fisher, Gideon Hirschfield*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)
414 Downloads (Pure)

Abstract

IL-12 is a pro-inflammatory cytokine that induces the production of interferon-γ (IFNγ) and favours the differentiation of T helper 1 (Th1) cells. In the presence of IL-12 human Treg cells acquire a Th1-like phenotype with reduced suppressive activity in vitro. Primary biliary cholangitis (PBC) is an autoimmune cholestatic liver disease characterised by high Th1 and Th17 infiltrating cells, reduced frequencies of Treg cells, and a genetic association with IL-12 signalling. Herein, we sought to evaluate the IL-12 signalling pathway in PBC pathology, by studying human samples from patients with PBC, alongside those with primary Sjögren’s syndrome (pSS)(autoimmune disease with IL-12 signalling gene association), primary sclerosing cholangitis (PSC) (cholestatic liver disease without IL-12 gene association) and healthy individuals. Our data revealed that TLR stimulation of PBC (n=17) and pSSmonocytes (n=6) resulted in significant induction of IL12A mRNA (p<0.05, p<0.01, respectively) compared to PSC monocytes (n=13) and at similar levels to HC monocytes (n=8). PSC monocytes expressed significantly less IL-12p70 (108pg/ml, mean) and IL-23 (358pg/ml) compared to HC (458pg/ml and 951pg/ml, respectively) (p<0.01, p<0.05). Treg cells from patients with PBC (n=16) and pSS (n=3) but not PSC (n=10) and HC (n=8) responded to low dose (10ng/ml) IL-12 stimulation by significant upregulation of IFNγ (55 and 186pg/ml, respectively) compared to PSC Treg cells (6pg/ml)(p<0.05). This effect was mediated by the rapid and strong phosphorylation of STAT4 on Treg cells from patients with PBC and pSS (p<0.05) but not PSC and HC. In the liver of patients with PBC (n=7) a significantly higher proportion of IL-12Rβ2+Tregs (16% on average) was detected (p<0.05) compared to other liver disease controls (5%)(n=18) which also showed ex vivo high IFNG and TBET expression. CONCLUSION: Our data show an increased sensitivity of PBC and pSS Treg cells to low dose IL-12 stimulation, providing ongoing support for the importance of the IL12-IL-12Rβ2-STAT4 pathway on Treg cells in disease pathogenesis and potentially treatment.
Original languageEnglish
Pages (from-to)143-155
Number of pages13
JournalJournal of Autoimmunity
Volume94
Early online date14 Aug 2018
DOIs
Publication statusPublished - Nov 2018

Keywords

  • Primary biliary cholangitis
  • primary sclerosing cholangitis
  • primary Sjögren’s syndrome
  • autoimmunity
  • T regulatory cells
  • Th1 cells

ASJC Scopus subject areas

  • Immunology and Microbiology(all)

Fingerprint

Dive into the research topics of 'Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells'. Together they form a unique fingerprint.

Cite this